Jean-Pol Tassin honored with the ECNP Neuropsychopharmacology Award

NewsGuard 100/100 Score

Pioneering and innovative research into the neurochemical basis of substance addiction

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

The ECNP Neuropsychopharmacology Award recognises outstanding research in the field of neuropsychopharmacology and its closely related disciplines. Granted annually, the award alternates between basic science and clinical research and is accompanied by a prize of EUR 20,000. Jean-Pol Tassin Tassin is the award's 31st recipient.

Jean-Pol Tassin, currently team leader at the Coll-ge de France's Molecular Genetic, Neurophysiology and Behaviour Laboratory in Paris, was drawn to addiction by his early research on nerve terminals in the prefrontal cortex and the effects of stress and long-term isolation on the meso-cortical pathway. Moving to studies on the impact of psychostimulants on cortical and sub-cortical neurons, his critical insight was to connect the disruption of nonadrenaline and serotonin neuron interaction with addictive behaviour. Jean-Pol Tassin's research showed how these neurons, when exposed to repeated psychostimulant abuse, become 'uncoupled,' thereby inducing distress, or withdrawal, for which further administrations of the drug are needed to achieve relief. Later refinements to this groundbreaking model have highlighted the key role played in tobacco addiction by monoamine inhibitors present in cigarettes.

Presenting the award at the 22nd ECNP Congress in Istanbul, the chairman of the ECNP Award Jury 2009, Tomas H-kfelt of the Karolinska Institute in Stockholm, commended Tassin's scientific originality as well as his landmark contribution to our understanding of this critical public health concern.

Jean-Pol Tassin's plenary lecture at the 22nd ECNP Congress has been recorded and is published on the ECNP website, www.ecnp.eu

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diet's role in fighting vitiligo highlighted in new research